Skip to Main Content

Paper Details

A Brief Analysis of Mesenchymal Stem Cells as Biological Drugs for the Treatment of Acute-on-Chronic Liver Failure (ACLF): Safety and Potency.
Curr Stem Cell Res Ther
6
2020
ACLF, Acute-on-Chronic Liver Failure, MSC, MSCs, Mesenchymal, Mesenchymal Stem Cells, chronic hepatitis, organ failure, patients
Author NameAffiliation
Meng ZhaoCell Products of National Engineering Research Center
Meng ZhaoNational Stem Cell Engineering Research Center
Meng ZhaoCell Products of National Engineering Research Center
Meng ZhaoNational Stem Cell Engineering Research Center
  • 1 - 4

Datasets

Release 1.2